100 Queen St, Suite 1300, World Exchange Plaza, Ottawa, ON
Year called to bar: 2003
Beverley practises in all areas of intellectual property litigation at Borden Ladner Gervais LLP, with a focus on patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations (NOC Regulations). She also advises clients on IP regulatory issues such as listing patents on the Patent Register, reporting patents to the Patented Medicines Prices Review Board (PMPRB), Certificates of Supplementary Protection, and the Register of Innovative Drugs as it relates to data protection. Beverley also advises on Access to Information (ATI) requests, in particular those made to Health Canada by pharmaceutical clients. In addition, Beverley advises on patent portfolio management, patentability, validity, and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada. Beverley is also active in the IP community as Director of the IPIC/McGill Understanding Patents Course, Co-Vice Chair of IPO’s Pharmaceutical and Biotechnology Issues Committee, and as an editor of Carswell’s Consolidated Intellectual Property Statues and Regulations. Beverley speaks and writes regularly on issues relating to her practice. Beverley has been an advocate before the Federal Court, the Federal Court of Appeal, and the Patented Medicine Prices Review Board.